AVGSF - Glympse Bio 2020 — Form D

AVGSF - Glympse Bio 2020 of Boston, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-06-01. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2020-06-01
• Form: D
• Accession: 0001810710-20-000001
• Industry: Pooled Investment Fund
• Exemptions: 06c, 3C, 3C.1
• Total offering: $2.7M
• Amount sold: $2.7M
• Minimum investment: $10K
• Investors: 106
• Date of first sale: 2020-05-29
• Security types: equity, fund interests
• Revenue range: $1 - $1,000,000
• SEC file number: 021-368067

Issuer

• Name: AVGSF - Glympse Bio 2020
• CIK: 0001810710
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 70 Federal Street, 6th Floor, Boston, MA, 02110
• Phone: 6035188112

Officers, directors & promoters (1)

More

• CIK 1810710 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search